Radial Artery Compression Device Market

The radial artery is located on the thumb side of the wrist, close to the skin, and is ideal for catheterization procedures. RACDs compress the radial artery during these procedures, reducing patient pain and discomfort. Furthermore, RACDs help reduces the time and costs associated with these procedures.

In addition, technological advancements in RACDs and favorable reimbursement policies are expected to fuel the growth of this market during the forecast period. However, the high cost of RACDs is a barrier to market growth.

The global radial artery compression device (RACD) market is divided into product type, application, end-user, and geography. It is divided into two categories based on product type: standalone devices and integrated systems. The two types of standalone devices are inflatable cuff devices and non-inflatable compression devices. Integrated systems are sub-segmented into manual systems and mechanical systems.

Minimally invasive surgeries are becoming more popular because they are less invasive than traditional surgeries. This is driving the growth of the radial artery compression device market. During the forecast period, the market is expected to grow because more people are getting heart diseases, technology is getting better, new products are being made, and there are more cath labs and cardiac catheterization procedures.

This report (US) looks at some of the major players in the market. These include Philips Healthcare (Netherlands), Medtronic (Ireland), Abbott Laboratories (US), Boston Scientific Corporation (US), Cardinal Health (US), Becton Dickinson and Company (US), and Johnson & Johnson Services, Inc.